The government has launched a second Investment Zone in Liverpool focused on life sciences. An initial £10 million investment will be made by US pharmaceutical manufacturer TriRx, to enhance its capabilities to manufacture monoclonal antibodies, a type of immunotherapy that work by blocking certain diseases from affecting healthy cells and are used to treat numerous … Continue reading Liverpool City Region is UK’s second Investment Zone